# Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology

> **NCT02861430** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 48 (actual)

## Conditions studied

- Colon Cancer
- Lymph Node
- Sentinel Node

## Interventions

- **PROCEDURE:** Immunochemistry and molecular biology on sentinel lymph node specimen

## Key facts

- **NCT ID:** NCT02861430
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-03
- **Final completion:** 2017-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02861430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02861430, "Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02861430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*